Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Nd:YAG vs Alexandrite Laser Treatment in Hidradenitis Suppurativa

NCT: NCT06960447 · NOT_YET_RECRUITING

NCT IDNCT06960447
StatusNOT_YET_RECRUITING
Start Date2026-07
Completion2027-07

Brief Summary

The purpose of this study is to evaluate whether Alexandrite laser treatment is non-inferior to Nd:YAG (neodymium-doped yttrium aluminum garnet) laser treatment of hidradenitis suppurativa (HS).

Frequently Asked Questions

What is Nd:YAG vs Alexandrite Laser Treatment in Hidradenitis Suppurativa?

Nd:YAG vs Alexandrite Laser Treatment in Hidradenitis Suppurativa is a clinical trial registered under NCT06960447. Current status: NOT_YET_RECRUITING.

What is the status of NCT06960447?

The current status of NCT06960447 (Nd:YAG vs Alexandrite Laser Treatment in Hidradenitis Suppurativa) is: NOT_YET_RECRUITING.

When did Nd:YAG vs Alexandrite Laser Treatment in Hidradenitis Suppurativa start?

Nd:YAG vs Alexandrite Laser Treatment in Hidradenitis Suppurativa started on 2026-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑